Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
1.33 USD | -5.00% | -3.60% | +14.53% |
05-13 | HC Wainwright Adjusts Price Target on Clearside Biomedical to $5 From $6, Keeps Buy Rating | MT |
05-09 | Transcript : Clearside Biomedical, Inc., Q1 2024 Earnings Call, May 09, 2024 |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+14.53% | 105M | |
+14.43% | 118B | |
+12.76% | 106B | |
-3.77% | 24.28B | |
+1.14% | 21.96B | |
-9.35% | 18.16B | |
-42.28% | 16.37B | |
-18.12% | 15.56B | |
+4.56% | 13.63B | |
+28.16% | 12.27B |
- Stock Market
- Equities
- CLSD Stock
- News Clearside Biomedical, Inc.
- Insider Trends: Insider Buying Prolonged with Purchase of Clearside Biomedical Shares